1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Hong Kong Pharmaceuticals and Healthcare Report Q3 2016

Hong Kong Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 99 pages

Includes 3 FREE quarterly updates

BMI View: Hong Kong's FY2016/17 budget will be largely positive for the healthcare sector. Additionalresources have been committed to develop the administrative region's medical infrastructure, while fundingfor healthcare programmes and the elderly continue to grow. A key downside has been the reduction infunds channelled into the Hospital Authority, which is already struggling to meet the existing demand formedical services. This will necessitate it to take a more conservative approach in its spending, to thedetriment of drugmakers seeking to list high-value medicines on the country's formulary.

Headline Expenditure Projections

- Pharmaceuticals: HKD13.0bn (USD1.7bn) in 2015 to HKD13.9bn (USD1.8bn) in 2016; +7.1% in localcurrency and 6.9% US dollars terms. Forecast upgraded from previous quarter.

- Healthcare: HKD142.2bn (USD18.3bn) in 2015 to HKD152.9bn (USD19.7bn) in 2016; +7.5% in localcurrency and 7.3% in US dollars terms. Forecast upgraded from previous quarter.

Table Of Contents

Hong Kong Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Hong Kong 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hong Kong 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 23
OTC Medicine Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Hong Kong 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Hong Kong 2014-2020) 29
Industry Risk/Reward Index 30
Asia Pacific Risk/Reward Index - Q3 2016 30
Hong Kong Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 38
Table: Processed Applications 39
Intellectual Property Issues 41
Pricing And Reimbursement Regime 43
Table: Number Of Drugs In Drug Formulary 44
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Hong Kong 2010-2015) 50
Table: Healthcare Personnel (Hong Kong 2010-2015) 50
Table: Healthcare Activity (Hong Kong 2010-2015) 51
Clinical Trials 57
Table: Top Causes Of Deaths In Hong Kong 60
Competitive Landscape 61
Research-Based Industry 61
Table: Multinational Market Activity 63
Pharmaceutical Distribution 64
Pharmaceutical Retail Sector 65
Company Profile 67
Wuyi International Pharmaceutical 67
CK Life Sciences 70
GlaxoSmithKline 74
Pfizer 77
Sanofi 80
Merck and Co 83
Novartis 85
Demographic Forecast 88
Table: Population Headline Indicators (Hong Kong 1990-2025) 89
Table: Key Population Ratios (Hong Kong 1990-2025) 89
Table: Urban/Rural Population and Life Expectancy (Hong Kong 1990-2025) 90
Table: Population By Age Group (Hong Kong 1990-2025) 90
Table: Population By Age Group % (Hong Kong 1990-2025) 91
Glossary 93
Methodology 95
Pharmaceutical Expenditure Forecast Model 95
Healthcare Expenditure Forecast Model 95
Notes On Methodology 96
Risk/Reward Index Methodology 97
Index Overview 98
Table: Pharmaceutical Risk/Reward Index Indicators 98
Indicator Weightings 99

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.